Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Chlorpromazine: In Vitro and In Vivo Evaluation. 2019

Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
Sulaiman Bin Abdullah Aba Al-Khail - Centre for Interdisciplinary Research in Basic Science (SA-CIRBS), International Islamic University, Islamabad 44000, Pakistan. jeand_baloch@yahoo.com.

Background and Objectives: Lipid-based self-nanoemulsifying drug delivery systems (SNEDDS) have resurged the eminence of nanoemulsions by modest adjustments and offer many valuable opportunities in drug delivery. Chlorpromazine, an antipsychotic agent with poor aqueous solubility-with extensive first-pass metabolism-can be a suitable candidate for the development of SNEDDS. The current study was designed to develop triglyceride-based SNEDDS of chlorpromazine to achieve improved solubility, stability, and oral bioavailability. Materials and Methods: Fifteen SNEDDS formulations of each short, medium, and long chain, triglycerides were synthesized and characterized to achieve optimized formulation. The optimized formulation was characterized for several in vitro and in vivo parameters. Results: Particle size, zeta potential, and drug loading of the optimized SNEDDS (LCT14) were found to be 178 ± 16, -21.4, and 85.5%, respectively. Long chain triglyceride (LCT14) showed a 1.5-fold increased elimination half-life (p < 0.01), up to 6-fold increased oral bioavailability, and 1.7-fold decreased plasma clearance rate (p < 0.01) compared to a drug suspension. Conclusion: The findings suggest that SNEDDS based on long-chain triglycerides (LCT14) formulations seem to be a promising alternative for improving the oral bioavailability of chlorpromazine.

UI MeSH Term Description Entries
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D045703 Emulsifying Agents SURFACE-ACTIVE AGENTS that induce a dispersion of undissolved material throughout a liquid. Emulsifying Agent,Emulsifyers,Agent, Emulsifying,Agents, Emulsifying
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
July 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
May 2017, Journal of microencapsulation,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
January 2010, International journal of pharmaceutics,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
January 2020, Current drug delivery,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
January 2023, Drug delivery and translational research,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
October 2013, Journal of pharmaceutical sciences,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
May 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
August 2020, Pharmaceutics,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
December 2013, Colloids and surfaces. B, Biointerfaces,
Jeand Baloch, and Muhammad Farhan Sohail, and Hafiz Shaib Sarwar, and Maria Hassan Kiani, and Gul Majid Khan, and Sarwat Jahan, and Muhammad Rafay, and Muhammad Tausif Chaudhry, and Masoom Yasinzai, and Gul Shahnaz
January 2021, Journal of pharmacy & bioallied sciences,
Copied contents to your clipboard!